Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 12 Projects
Project # Contact PI Funding Organization Fiscal Year
Long-Term Nicotine Treatment of Mild Cognitive Impairment - Bridge Funding
3R01AG047992-06S1 NEWHOUSE, PAUL A. NIA 2020
Pathophysiology of postoperative delirium and the use of biomimetic sleep as a treatment strategy in the CSICU
3R01AG053582-05S1 JOHNSON-AKEJU, OLUWASEUN NIA 2020
A Randomized; Double-blind; Placebo-Controlled; Parallel-Group; Phase II Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Mild to Moderate Alzheimer's Disease
3R01AG058660-03S2 CATALANO, SUSAN M NIA 2020
Administrative Supplement for 1R01AG059008-01: Requested for investigational drug expenses
3R01AG059008-02S1 SABBAGH, MARWAN N NIA 2020
Phase 2 Randomized; Double-Blind; Placebo-Controlled Clinical Trial of T3D-959 in Mild to Moderate Alzheimer's Disease Subjects
3R01AG061122-02S1 DIDSBURY, JOHN NIA 2020
A randomized; double blind; placebo-controlled study to evaluate the impact of Nilotinib treatment on safety; tolerability; pharmacokinetics and biomarkers in Dementia with Lewy Bodies (DLB)
3R01AG062463-02S1 MOUSSA, CHARBEL NIA 2020
Coverage for costs associated with reading of amyloid PET images from PARIS study
3R44AG059489-03S1 WEST, TIM NIA 2020
Increasing size of Phase 2b clinical trial to 60 patients
3R44AG060878-02S1 BURNS, LINDSAY H. NIA 2020
Clinical trials to prevent Alzheimer's Disease in Down Syndrome
3R61AG066543-02S1 RAFII, MICHAEL S NIA 2020
A Pilot Synaptic Vesicle Glycoprotein 2A (SV2A) PET Study to Evaluate the Effect of CT1812 Treatment on Synaptic Density in Subjects with Mild to Moderate Alzheimer's Disease
3RF1AG057553-01S2 CATALANO, SUSAN M NIA 2020